Although, we identified that SNHG3 and SNHG15 may have great clinical value to act as diagnostic biomarkers and indicators to evaluate the survival and progression of ccRCC, the number of cases can still be improved. This evidence concerns the gene SNHG3 and nonpapillary renal cell carcinoma.